Arrowhead Pharmaceuticals Inc. (ARWR) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Arrowhead Pharmaceuticals Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$60.21
+2.00% today
Market cap
$8.3B
Overall quality
48/100
Kronos AI 30-day
+29.3%
8 of 8 simulated paths end higher
Arrowhead Pharmaceuticals Inc. (ARWR) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $8.3B. It trades at $60.21, up 2.00% today. Its overall quality score is 48 out of 100, ranked against the whole US market. 12 analysts' average target of $109.00 implies +81.0% from today's price. Kronos AI's 30-day forecast is +29.3% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $109.00 |
| Low – high | $74.00 – $126.00 |
| Analysts | 12 |
| Upside to average | +81.0% |
Kronos AI 30-day forecast
| Expected close | $76.34 (+29.3%) |
| Likely range | +26.3% … +37.0% |
| As of | 2026-10-27 |
8 of 8 simulated paths end higher.
Quality scores
| Profitability | 20 |
| Solvency | 33 |
| Growth | 90 |
| Overall | 48 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.